On June 26, 2025, VisualDx released new images and clinical content to its subscribers. Want to experience it for yourself? Start your free 7-day trial.
Here is what we focused on:
- Adding oncodermatology-related diagnoses. It’s estimated that more than half of patients undergoing cancer treatment will experience skin-related complications. The skin, hair, nails, and oral mucosa can all be adversely affected by oncologic therapies. Enhanced dermatologic care is crucial to address these issues, ensuring timely diagnosis, effective management, and improved overall patient outcomes.
- Refreshing older images sets with new great images such as atypical nevus, DRESS, erythema multiforme, fixed and exanthematous drug reactions, hand dermatitis, infectious eczematoid dermatitis, lobular capillary hemangioma, and nummular dermatitis.
- Reorganizing our drug classes to better represent oncodermatology. This means a better differential for you when you enter a drug as your chief complaint. (Did you know you can do that? Learn more about it here.)
4,349
Total Findings
13 New Added
3,715
Total Diagnoses
19 New Added
49,597
Total Images
471 New Added
NEW Diagnoses
DERMATOLOGY / DRUG-INDUCED ADVERSE EFFECTS
- Amyloid-related imaging abnormality (ARIA)
- Demodex blepharitis
- Drug-induced xerostomia
- Fracture blister
- Paradoxical psoriasis
- Physiologic volar melanotic macules
- Smokeless tobacco keratosis
INFECTIOUS DISEASE
INTERNAL MEDICINE / OBGYN
MUSCULOSKELETAL / ORTHO
ONCODERMATOLOGY
ONCOLOGY / HEMATOLOGY / DRUG-INDUCED ADVERSE EFFECTS